Harris Associates’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Buy |
+3,163
| New | +$587K | ﹤0.01% | 130 |
|
|
2024
Q3 | – | Sell |
-1,493
| Closed | -$256K | – | 147 |
|
|
2024
Q2 | $256K | Buy |
1,493
+93
| +7% | +$16K | ﹤0.01% | 128 |
|
|
2024
Q1 | $255K | Sell |
1,400
-1,400
| -50% | -$255K | ﹤0.01% | 130 |
|
|
2023
Q4 | $434K | Sell |
2,800
-455
| -14% | -$70.5K | ﹤0.01% | 130 |
|
|
2023
Q3 | $485K | Hold |
3,255
| – | – | ﹤0.01% | 128 |
|
|
2023
Q2 | $439K | Buy |
+3,255
| New | +$439K | ﹤0.01% | 136 |
|
|
2018
Q3 | – | Sell |
-22,429
| Closed | -$2.08M | – | 124 |
|
|
2018
Q2 | $2.08M | Sell |
22,429
-18,871
| -46% | -$1.75M | ﹤0.01% | 118 |
|
|
2018
Q1 | $3.91M | Sell |
41,300
-800
| -2% | -$75.7K | 0.01% | 119 |
|
|
2017
Q4 | $4.07M | Sell |
42,100
-18,950
| -31% | -$1.83M | 0.01% | 114 |
|
|
2017
Q3 | $5.43M | Buy |
61,050
+37,350
| +158% | +$3.32M | 0.01% | 114 |
|
|
2017
Q2 | $1.72M | Buy |
+23,700
| New | +$1.72M | ﹤0.01% | 112 |
|
|
2015
Q3 | – | Sell |
-5,759
| Closed | -$387K | – | 122 |
|
|
2015
Q2 | $387K | Sell |
5,759
-32,699
| -85% | -$2.2M | ﹤0.01% | 133 |
|
|
2015
Q1 | $2.25M | Sell |
38,458
-3,963
| -9% | -$232K | ﹤0.01% | 125 |
|
|
2014
Q4 | $2.78M | Sell |
42,421
-36
| -0.1% | -$2.36K | ﹤0.01% | 133 |
|
|
2014
Q3 | $2.45M | Hold |
42,457
| – | – | ﹤0.01% | 130 |
|
|
2014
Q2 | $2.4M | Sell |
42,457
-1,734
| -4% | -$97.9K | ﹤0.01% | 131 |
|
|
2014
Q1 | $2.27M | Sell |
44,191
-1,865
| -4% | -$95.8K | ﹤0.01% | 131 |
|
|
2013
Q4 | $2.43M | Hold |
46,056
| – | – | ﹤0.01% | 134 |
|
|
2013
Q3 | $2.06M | Buy |
46,056
+497
| +1% | +$22.2K | ﹤0.01% | 135 |
|
|
2013
Q2 | $1.88M | Buy |
+45,559
| New | +$1.88M | ﹤0.01% | 143 |
|